UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors
Dave S.B. Hoon, Ph.D., Professor and Director of Dept. of Translational Molecular Medicine and his team have published a new article in Cell Journal.
Early loss of Histone H2B monoubiquitylation alters chromatin accessibility and activates key immune pathways that facilitate progression of ovarian cancer
Dave S.B. Hoon, Ph.D., Professor and Director of Dept. of Translational Molecular Medicine in collaboration with the University of Pennsylvania have published a new article in Cancer Research Journal.
Men’s Health Webinar – Registration Confirmation
Thank you! You have successfully registered for the Men’s Health Webinar Understanding BPH and Aquablation Therapy Date: Thursday, June 5,…
Glioblastoma: Prognosis Treatment & Standard of Care
Glioblastoma is a cancer of the brain that’s difficult to treat because it invades the normal brain structure. Hear about the current and future treatment options for this deadly disease from Santosh Kesari M.D., Chair of Translational Neurosciences.
Lipid–Polymer Hybrid Nanoparticles as a Next-Generation Drug Delivery Platform: State of the Art, Emerging Technologies, and Perspectives
Learn about Lipid–polymer hybrid nanoparticles (LPHNPs) and the recent key advancements for future clinical possibilities, from Venkata Yenugonda, M.Phil, Ph.D., Associate Professor, Department of Translational Neurosciences, and Director, Drug Discovery and Nanomedicine.